Literature DB >> 15973775

Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in association with neovascularization in human primary astrocytoma.

Jian-Wei Pan1, Ren-ya Zhan, Ying Tong, Yong-qing Zhou, Ming Zhang.   

Abstract

OBJECTIVE: To investigate the relationship between the expression of endothelial nitric oxide synthase (eNOS), vascular endothelial growth factor (VEGF) and angiogenesis in primary astrocytoma.
METHODS: Thirty-seven primary astrocytomas and 4 astrocytic hyperplasia samples were collected and divided into three groups according to histological grade. The expression of eNOS, VEGF and factor VIII related antigen (FVIIIRAg) were assayed by immunohistochemistry. Microvascular density was assessed by FVIIIRAg immunoreactivity. The intensity of immunoreactivity was graded according to the percentage of positive tumor cells.
RESULTS: No eNOS and VEGF were expressed in the astrocytes and vascular endothelium in astrocytic hyperplasia. The expression of eNOS or VEGF was light in low-grade astrocytoma and strong in glioblastoma. eNOS expression in astrocytoma was very positively correlated with VEGF. eNOS and VEGF expression in anaplastic astrocytoma was median in contrast to the low grade astrocytoma and glioblastoma. Lower microvascular density was found in low grade astrocytoma than that in higher grade malignant ones. The expressions of eNOS and VEGF were correlated with microvascular density and tumor malignancy.
CONCLUSION: This finding suggests that eNOS and VEGF may have cooperative effect in tumor angiogenesis and play an important role in the pathogenesis of primary astrocytoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15973775      PMCID: PMC1389807          DOI: 10.1631/jzus.2005.B0693

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  17 in total

1.  The effects of chronic nitric oxide synthase suppression on glioma pathophysiology.

Authors:  G R Swaroop; P A Kelly; H S Bell; J Shinoda; S Yamaguchi; I R Whittle
Journal:  Br J Neurosurg       Date:  2000-12       Impact factor: 1.596

Review 2.  Nitric oxide and angiogenesis.

Authors:  M Ziche; L Morbidelli
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

3.  Correlation of bFGF, FGFR-1 and VEGF expression with vascularity and malignancy of human astrocytomas.

Authors:  X W Bian; L L Du; J Q Shi; Y S Cheng; F X Liu
Journal:  Anal Quant Cytol Histol       Date:  2000-06       Impact factor: 0.302

Review 4.  Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family.

Authors:  I Zachary; G Gliki
Journal:  Cardiovasc Res       Date:  2001-02-16       Impact factor: 10.787

5.  Nitric oxide modulates capillary formation at the endothelial cell-tumor cell interface.

Authors:  P G Phillips; L M Birnby; A Narendran; W L Milonovich
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-07       Impact factor: 5.464

6.  Vascular endothelial growth factor up-regulates nitric oxide synthase expression in endothelial cells.

Authors:  A Bouloumié; V B Schini-Kerth; R Busse
Journal:  Cardiovasc Res       Date:  1999-03       Impact factor: 10.787

7.  Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability.

Authors:  D Fukumura; T Gohongi; A Kadambi; Y Izumi; J Ang; C O Yun; D G Buerk; P L Huang; R K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

8.  Genetic disruption of host nitric oxide synthase II gene impairs melanoma-induced angiogenesis and suppresses pleural effusion.

Authors:  B Wang; Q Xiong; Q Shi; D Tan; X Le; K Xie
Journal:  Int J Cancer       Date:  2001-03-01       Impact factor: 7.396

9.  Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt.

Authors:  M Morales-Ruiz; D Fulton; G Sowa; L R Languino; Y Fujio; K Walsh; W C Sessa
Journal:  Circ Res       Date:  2000-04-28       Impact factor: 17.367

10.  Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide.

Authors:  H Kimura; A Weisz; Y Kurashima; K Hashimoto; T Ogura; F D'Acquisto; R Addeo; M Makuuchi; H Esumi
Journal:  Blood       Date:  2000-01-01       Impact factor: 22.113

View more
  5 in total

Review 1.  NOS Expression and NO Function in Glioma and Implications for Patient Therapies.

Authors:  Anh N Tran; Nathaniel H Boyd; Kiera Walker; Anita B Hjelmeland
Journal:  Antioxid Redox Signal       Date:  2016-08-25       Impact factor: 8.401

2.  Different effects of L-arginine on morphine tolerance in sham and ovariectomized female mice.

Authors:  Reza Karami; Mahmoud Hosseini; Fatimeh Khodabandehloo; Leila Khatami; Zahra Taiarani
Journal:  J Zhejiang Univ Sci B       Date:  2011-12       Impact factor: 3.066

3.  T11TS impedes glioma angiogenesis by inhibiting VEGF signaling and pro-survival PI3K/Akt/eNOS pathway with concomitant upregulation of PTEN in brain endothelial cells.

Authors:  Debanjan Bhattacharya; Manoj Kumar Singh; Suhnrita Chaudhuri; Sagar Acharya; Anjan Kumar Basu; Swapna Chaudhuri
Journal:  J Neurooncol       Date:  2013-03-08       Impact factor: 4.130

4.  Aberrant up-regulation of iNOS/NO system is correlated with an increased abundance of Foxp3+ cells and reduced effector/memory cell markers expression during colorectal cancer: immunomodulatory effects of cetuximab combined with chemotherapy.

Authors:  Sarra Benkhelifa; Hayet Rafa; Said Belhadef; Hayat Ait-Kaci; Oussama Medjeber; Mourad Belkhelfa; Sabah Hetit; Sonia Ait-Younes; Yvan De Launoit; Olivier Moralès; Hassen Mahfouf; Nadira Delhem; Chafia Touil-Boukoffa
Journal:  Inflammopharmacology       Date:  2019-01-24       Impact factor: 4.473

Review 5.  Contribution of the Microenvironmental Niche to Glioblastoma Heterogeneity.

Authors:  Ivy A W Ho; Winston S N Shim
Journal:  Biomed Res Int       Date:  2017-05-28       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.